ERP disclosed a US warehouse expansion in a single community post, citing inbound stock exceeding 50,000 units across compounds including BPC-157, tesamorelin, HCG, SS-31, and NAD-precursor formulations, with introductory pricing set at $74 for Tr15 and $69 for GHK-CU100. Separately, a community member Emmy posted introductory pricing on two SKUs: "Tr15 - $74" and "GHK-CU100 - $69," with bulk discounts noted as available.
The post generated no community responses within the observed window, consistent with the default low-engagement environment for vendor inventory announcements; the silence carries no implication for fulfillment health or verification practices, most of which move through private channels.
“📦 In Stock✦(US warehouse) 🔸• TR 30 🔸• TR 60 🔸• RT 10 🔸• RT 20 🔸• RT 30 🔸• BB 10 (BPC 5mg + TB 5mg) 🔸• BB 20 🔸• MOTS-C 10 🔸• KLOW 80mg 🔸• NAD+500 🔸• NAD+1000 🔸• GHK-CU 50 🔸• AHK-CU 100 🔸• Tesamorelin 10 ✦ HCG 5000 ✦ BPC-157 10mg 🔹• GLOW70 🔹• Glutathione600mg Shipping fee $20 ⏳ Pending Arrival (Not Yet in US Warehouse) ✦ MOTS-C 40—— (800 kits) ✦ MT 2 10mg—— (600 kits) ✦ H10iu—— (500 kits) ✦ H24iu—— (800 kits) ✦ H36iu—— (800 kits) ✦ KPV10——(400 kits) ✦ SS31—— (300 kits) ✦ XA10—— (300 kits) ✦ SK10…”
— anon-b9269030ccca, 2026-01-25 · 3 reactions